BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 15273263)

  • 41. Environmental conditions, political economy, and rates of injection drug use in large US metropolitan areas 1992-2002.
    Roberts ET; Friedman SR; Brady JE; Pouget ER; Tempalski B; Galea S
    Drug Alcohol Depend; 2010 Jan; 106(2-3):142-53. PubMed ID: 19748745
    [TBL] [Abstract][Full Text] [Related]  

  • 42. High risk behavior for HIV transmission among former injecting drug users: a survey from Indonesia.
    Iskandar S; Basar D; Hidayat T; Siregar IM; Pinxten L; van Crevel R; Van der Ven AJ; De Jong CA
    BMC Public Health; 2010 Aug; 10():472. PubMed ID: 20698979
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Feasibility of one-time use of sterile syringes: a study of active injection drug users in seven United States metropolitan areas.
    Gleghorn AA; Wright-De Agüero L; Flynn C
    J Acquir Immune Defic Syndr Hum Retrovirol; 1998; 18 Suppl 1():S30-6. PubMed ID: 9663621
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Alarming epidemics of human immunodeficiency virus and hepatitis C virus among injection drug users in the northwestern bordering state of Punjab, India: prevalence and correlates.
    Panda S; Roy T; Pahari S; Mehraa J; Sharma N; Singh G; Singh J; Joseph F; Singh S; Sharma NM
    Int J STD AIDS; 2014 Jul; 25(8):596-606. PubMed ID: 24352120
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Estimating the population prevalence of injection drug use and infection with human immunodeficiency virus among injection drug users in Glasgow, Scotland.
    Frischer M; Leyland A; Cormack R; Goldberg DJ; Bloor M; Green ST; Taylor A; Covell R; McKeganey N; Platt S
    Am J Epidemiol; 1993 Aug; 138(3):170-81. PubMed ID: 8356960
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Interventions with injection drug users in Ukraine.
    Booth RE; Lehman WE; Dvoryak S; Brewster JT; Sinitsyna L
    Addiction; 2009 Nov; 104(11):1864-73. PubMed ID: 19681800
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Convergence of HIV seroprevalence among injecting and non-injecting drug users in New York City.
    Des Jarlais DC; Arasteh K; Perlis T; Hagan H; Abdul-Quader A; Heckathorn DD; McKnight C; Bramson H; Nemeth C; Torian LV; Friedman SR
    AIDS; 2007 Jan; 21(2):231-5. PubMed ID: 17197815
    [TBL] [Abstract][Full Text] [Related]  

  • 48. An international comparative study of HIV prevalence and risk behaviour among drug injectors in 13 cities. WHO Collaborative Study Group.
    Bull Narc; 1993; 45(1):19-46. PubMed ID: 8305904
    [TBL] [Abstract][Full Text] [Related]  

  • 49. A cross-sectional study on factors including HIV testing and counselling determining unsafe injecting practices among injecting drug users of Manipur.
    Sarkar S; Panda S; Sarkar K; Hangzo CZ; Bijaya L; Singh NY; Das N; Agarwal A; Chatterjee A; Deb BC
    Indian J Public Health; 1995; 39(3):86-92. PubMed ID: 8690497
    [TBL] [Abstract][Full Text] [Related]  

  • 50. HIV transmission from drug injectors to partners who do not inject, and beyond: modelling the potential for a generalized heterosexual epidemic in St. Petersburg, Russia.
    Mills HL; White E; Colijn C; Vickerman P; Heimer R
    Drug Alcohol Depend; 2013 Nov; 133(1):242-7. PubMed ID: 23692991
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Application of BED-CEIA to estimate the human immunodeficiency virus prevalence among injecting drug users in Chongqing municipality].
    Han M; Wang YL; Wang MJ; Zhou QH; Jiang Y
    Zhonghua Liu Xing Bing Xue Za Zhi; 2007 Nov; 28(11):1077-80. PubMed ID: 18396659
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Risk behavior and HIV infection among new drug injectors in the era of AIDS in New York City.
    Des Jarlais DC; Friedman SR; Perlis T; Chapman TF; Sotheran JL; Paone D; Monterroso E; Neaigus A
    J Acquir Immune Defic Syndr Hum Retrovirol; 1999 Jan; 20(1):67-72. PubMed ID: 9928732
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Injecting alone among young adult IDUs in five US cities: evidence of low rates of injection risk behavior.
    Hagan H; Campbell JV; Thiede H; Strathdee SA; Ouellet L; Latka M; Hudson S; Garfein RS;
    Drug Alcohol Depend; 2007 Nov; 91 Suppl 1(Suppl 1):S48-55. PubMed ID: 17363193
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Socio-behavioral and geographic correlates of prevalent hepatitis C virus infection among young injection drug users in metropolitan Baltimore and Chicago.
    Boodram B; Golub ET; Ouellet LJ
    Drug Alcohol Depend; 2010 Sep; 111(1-2):136-45. PubMed ID: 20472373
    [TBL] [Abstract][Full Text] [Related]  

  • 55. HCV prevalence and risk behaviours among injectors of new psychoactive substances in a risk environment in Hungary-An expanding public health burden.
    Tarján A; Dudás M; Wiessing L; Horváth G; Rusvai E; Tresó B; Csohán Á
    Int J Drug Policy; 2017 Mar; 41():1-7. PubMed ID: 27984762
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Improving survey methods in sero-epidemiological studies of injecting drug users: a case example of two cross sectional surveys in Serbia and Montenegro.
    Judd A; Rhodes T; Johnston LG; Platt L; Andjelkovic V; Simić D; Mugosa B; Simić M; Zerjav S; Parry RP; Parry JV
    BMC Infect Dis; 2009 Feb; 9():14. PubMed ID: 19203380
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Estimating prevalence of injecting drug use: a comparison of multiplier and capture-recapture methods in cities in England and Russia.
    Hickman M; Hope V; Platt L; Higgins V; Bellis M; Rhodes T; Taylor C; Tilling K
    Drug Alcohol Rev; 2006 Mar; 25(2):131-40. PubMed ID: 16627302
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Correlates of injecting in an HIV incidence hotspot among substance users in Tijuana, Mexico.
    Kori N; Roth AM; Lozada R; Vera A; Brouwer KC
    Int J Drug Policy; 2014 May; 25(3):525-32. PubMed ID: 24418632
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Low knowledge and perceived Hepatitis C risk despite high risk behaviour among injection drug users in Kathmandu, Nepal.
    Loewinger G; Sharma B; Karki DK; Khatiwoda P; Kainee S; Poudel KC
    Int J Drug Policy; 2016 Jul; 33():75-82. PubMed ID: 27318773
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Entry of human immunodeficiency virus infection into a population of injecting drug users, Victoria, 1990.
    Crofts N; Hay M
    Med J Aust; 1991 Sep; 155(6):378-82. PubMed ID: 1921786
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.